Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer.

Ian M McElree,Vignesh T Packiam,Ryan L Steinberg,Sarah L Mott,Paul T Gellhaus,Kenneth G Nepple,Michael A O'Donnell

The Journal of urology（2022）

引用 2|浏览8

暂无评分

摘要

In a heavily pretreated population, our results suggest valrubicin and docetaxel is an effective rescue treatment for patients with recurrent non-muscle-invasive bladder cancer. Further prospective evaluation is needed.

查看译文

关键词

docetaxel,urinary bladder neoplasms,valrubicin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要